HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renoprotective effects of gamma-aminobutyric acid on ischemia/reperfusion-induced renal injury in rats.

Abstract
Enhanced renal sympathetic nerve activity during ischemic period and the renal venous norepinephrine overflow after reperfusion play important roles in the development of ischemic acute kidney injury. We investigated the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter mainly in the central nervous system, on ischemia/reperfusion-induced acute kidney injury in anesthetized rats. Ischemic acute kidney injury was induced by clamping the left renal artery and vein for 45min followed by reperfusion 2weeks after the contralateral nephrectomy. Intravenous injection of GABA (10 and 50micromol/kg) to ischemic acute kidney injury rats dose-dependently suppressed the enhanced renal sympathetic nerve activity during the renal ischemia, the renal venous norepinephrine overflow after reperfusion and attenuated the ischemia/reperfusion-induced renal dysfunction with histological damage. Intravenous injection of CGP52432 (0.1micromol/kg), a selective GABA(B) receptor antagonist, eliminated the preventive effect by GABA (50micromol/kg) on ischemic acute kidney injury. In contrast, intravenous injection of baclofen (1micromol/kg), a selective GABA(B) receptor agonist, attenuated the ischemia/reperfusion-induced renal injury equivalent to GABA (50micromol/kg). These results indicate that GABA prevents the development of ischemia/reperfusion-induced acute kidney injury presumably via GABA(B) receptor, by suppressing the enhanced renal sympathetic nerve activity during ischemia and the increased norepinephrine overflow from renal sympathetic nerve ending.
AuthorsShuhei Kobuchi, Takuya Shintani, Takahiro Sugiura, Ryosuke Tanaka, Rie Suzuki, Hidenobu Tsutsui, Toshihide Fujii, Mamoru Ohkita, Kazuhide Ayajiki, Yasuo Matsumura
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 623 Issue 1-3 Pg. 113-8 (Nov 25 2009) ISSN: 1879-0712 [Electronic] Netherlands
PMID19765583 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzylamines
  • GABA Agonists
  • GABA Antagonists
  • GABA-B Receptor Antagonists
  • Phosphinic Acids
  • CGP 52432
  • gamma-Aminobutyric Acid
  • Baclofen
  • Norepinephrine
Topics
  • Animals
  • Baclofen (pharmacology)
  • Benzylamines (pharmacology)
  • GABA Agonists (pharmacology)
  • GABA Antagonists (pharmacology)
  • GABA-B Receptor Antagonists
  • Kidney (blood supply, innervation, pathology, physiopathology)
  • Kidney Diseases (pathology, physiopathology, prevention & control)
  • Kidney Function Tests
  • Kidney Tubular Necrosis, Acute (pathology, prevention & control)
  • Male
  • Neurons (physiology)
  • Norepinephrine (blood)
  • Phosphinic Acids (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (physiopathology, prevention & control)
  • Sympathetic Nervous System (physiopathology)
  • Time Factors
  • gamma-Aminobutyric Acid (administration & dosage, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: